Coexistence of Hodgkin and Non-Hodgkin lymphoma; Composite Lymphoma (CL) in a patient presenting with waxing and waning lymphadenopathy.
Conclusion: Composite lymphomas pose a particular diagnostic challenge, and currently there are no agreed standards for treatment (4).
PMID: 31633478 [PubMed - as supplied by publisher]
Source: Cardiovascular and Hematological Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Cardiovasc Hematol Disord Drug Targets Source Type: research
More News: Cardiology | Cardiovascular | Drugs & Pharmacology | Heart | Hematology | Hodgkin's Disease | Laboratory Medicine | Lymphoma | Non-Hodgkin's Lymphoma | Rare Diseases